Sonnet BioTherapeutics Holdings
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	9/30/2022	9/30/2023	9/30/2024	9/30/2025	9/30/2026	9/30/2027
Revenue % change YoY	$349.94K N/A	$147.80K -57.76%	$18.62K -87.39%	Avg: $42.54K Low: $42.54K High: $42.54K avg. 128.39%	Avg: $22.82K Low: $22.82K High: $22.82K avg. -46.35%	Avg: $12.24K Low: $12.24K High: $12.24K avg. -46.35%
Net Income % change YoY	$-29.77M N/A	$-18.83M 36.74%	$-7.43M 60.50%	Avg: $-17.57M Low: $-2.61M High: $-2.61M avg. -136.24%	Avg: $-28M Low: $-12.79M High: $-12.79M avg. -59.36%	Avg: $-12.56M Low: $-12.56M High: $-12.56M avg. 55.13%
EBITDA % change YoY	$-29.61M N/A	$-18.71M 36.80%	$-11.84M 36.69%	Avg: $-18.00K Low: $-18.00K High: $-18.00K avg. 99.84%	Avg: $-9.65K Low: $-9.65K High: $-9.65K avg. 46.35%	Avg: $-5.18K Low: $-5.18K High: $-5.18K avg. 46.34%
EPS % change YoY	-$150.79 N/A	-$18.14 87.97%	-$11.35 37.43%	Avg: -$2.52 Low: -$2.52 High: -$2.52 avg. 77.79%	Avg: -$12.32 Low: -$12.32 High: -$12.32 avg. -388.88%	Avg: -$12.1 Low: -$12.1 High: -$12.1 avg. 1.78%
Operating Expenses % change YoY	$30.01M N/A	$18.94M -36.90%	$11.86M -37.33%	Avg: $784.92K Low: $784.92K High: $784.92K avg. -93.38%	Avg: $421.08K Low: $421.08K High: $421.08K avg. -46.35%	Avg: $225.91K Low: $225.91K High: $225.91K avg. -46.35%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of -46.82% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -2.61M, average is -17.57M and high is -2.61M.

Wall Street analysts forecast annual average revenue growth of 11.89% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $42.54K, average is $42.54K and high is $42.54K.

Wall Street analysts forecast annual average earnings growth of -103.10% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$2.52, average is -$2.52 and high is $-2.52.